Medicare Enrolled
Dr. John Moretto, MD
Clinical Pathology/Laboratory Medicine Physician · San Francisco, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moretto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moretto?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moretto
Dr. John Moretto is a clinical pathology/laboratory medicine physician in San Francisco, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Moretto performed 6,465 Medicare services across 3,807 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moretto received a total of $139 from 5 pharmaceutical and/or device companies across 5 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical pathology/laboratory medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moretto is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in CA
$139 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,465
Medicare services
Top 3% in CA for clinical pathology/laboratory medicine physician
3,807
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~323 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
2,597 | $32 | $300 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
1,161 | $25 | $299 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
822 | $31 | $299 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
276 | $24 | $170 |
| Moderately high complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation. |
253 | $74 | $500 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
196 | $38 | $360 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
181 | $11 | $77 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
165 | $10 | $179 |
| Limited pathology tissue examination A microscopic examination of tissue samples to identify abnormalities. This limited exam focuses on specific aspects of the tissue rather than a comprehensive analysis. |
115 | $4 | $57 |
| Genetic analysis of archival tissue Testing stored tissue samples to identify genetic information. This procedure analyzes existing tissue specimens for genetic markers. |
80 | $17 | $300 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
74 | $24 | $167 |
| Surgical pathology consultation on referred slides A pathologist reviews and reports on tissue slides that were prepared at another facility. This service provides a second opinion or expert analysis of the existing samples. |
73 | $74 | $225 |
| Additional antibody stain test An additional laboratory test using a single antibody stain to evaluate specific markers. |
72 | $25 | $199 |
| Intraoperative pathology examination, first tissue block A pathologist examines a tissue sample removed during surgery to provide a preliminary diagnosis. This test is performed on the first tissue block obtained from the procedure. |
63 | $57 | $434 |
| X-ray of surgical specimen | 49 | $13 | $57 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
46 | $32 | $318 |
| Tissue preparation to remove calcium A laboratory procedure that removes calcium from a tissue sample to prepare it for microscopic examination. |
39 | $11 | $63 |
| Pathology examination of specimen during surgery A pathologist examines tissue removed during surgery to determine its nature. This analysis helps guide immediate surgical decisions. |
37 | $32 | $252 |
| Fine needle aspirate evaluation and report A pathologist examines cells collected via a fine needle aspiration and provides a written interpretation and report of the findings. |
23 | $64 | $407 |
| Intraoperative pathology examination of specimen A pathology test performed during surgery to examine a tissue sample from the initial site. The results help guide the surgeon's immediate decisions. |
22 | $57 | $681 |
| High complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope using advanced techniques to analyze cellular details. |
21 | $132 | $813 |
| Fine needle aspirate evaluation A laboratory examination of cells collected via fine needle aspiration to assess for abnormalities. |
19 | $32 | $230 |
| Initial single antibody stain evaluation A laboratory test that uses a single antibody stain to evaluate specific proteins or markers in a sample. |
18 | $31 | $296 |
| Genetic sequencing localization, initial procedure This procedure involves the initial process of localizing genetic sequencing. It identifies the specific location of genetic material for further analysis. |
17 | $39 | $315 |
| Additional Pap test evaluation episode An additional immediate evaluation of a fine needle aspirate sample during a Pap test procedure. |
16 | $20 | $230 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 16 | $29 | $70 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
14 | $147 | $1,350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
0.2% medium
99.2% routine
Industry Payment Transparency
Open Payments through 2020 ↗$139
Total received (2018-2020)
Avg $46/year across 3 years
Bottom 41% in CA for clinical pathology/laboratory medicine physician
5
Companies
5
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$139 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2020
$16
2019
$19
2018
$103
Payments by company (2020)
Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$16
Top 3 companies account for 100.0% of 2020 payments
All-time payments by company (2018-2020) ›
Foundation Medicine, Inc.
$54
Roche Diagnostics Corporation
$28
United Therapeutics Corporation
$21
Merck Sharp & Dohme Corporation
$19
Genentech USA, Inc.
$16
Top 3 companies account for 74.3% of all-time payments
Associated products mentioned in payments ›
FOUNDATIONONE · KEYTRUDA · ORENITRAM · TD BenchMark IHC/ISH and Special Stains Reagents
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Clinical pathology/laboratory medicine physicians within 10 mi
28
Per 100K population
3.3
County median income
$141,446
Nearest hospital
CALIFORNIA PACIFIC MEDICAL CTR-DAVIES CAMPUS HOSP
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2020 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moretto is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moretto experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Moretto performed 2,597 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moretto receive payments from pharmaceutical companies?
Yes. Dr. Moretto received a total of $139 from 5 companies across 5 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moretto's costs compare to other clinical pathology/laboratory medicine physicians in San Francisco?
Dr. Moretto's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moretto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical Pathology/laboratory Medicine Physicians in San Francisco
Browse clinical pathology/laboratory medicine physicians in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Clinical Pathology/laboratory Medicine Physicians in CA
Clinical pathology/laboratory medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Pathology/laboratory Medicine Physicians in CA
Which CA clinical pathology/laboratory medicine physicians receive the most from drug and device companies.
By company
Foundation Medicine, Inc. Payments to Doctors
See all physicians who received payments from Foundation Medicine, Inc.
By company
Roche Diagnostics Corporation Payments to Doctors
See all physicians who received payments from Roche Diagnostics Corporation.
By company
United Therapeutics Corporation Payments to Doctors
See all physicians who received payments from United Therapeutics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology